Simeprevir Plus Peginterferon/Ribavirin Cost-Effectiveness Analysis for the Treatment of Chronic Genotype 1 Hepatitis C in Mexico
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.018
https://www.valueinhealthjournal.com/article/S1098-3015(15)02094-X/fulltext
Title :
Simeprevir Plus Peginterferon/Ribavirin Cost-Effectiveness Analysis for the Treatment of Chronic Genotype 1 Hepatitis C in Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02094-X&doi=10.1016/j.jval.2015.09.018
First page :
A872
Section Title :
Research Podium Presentations - Session 1
Open access? :
No
Section Order :
2772